Ptc Therapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC PTCT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

131,893

Value ($000)

10,019

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	10,019	0.0%	131,893	12/31/2025
2025 Q3	11/14/2025	7,972	0.0%	129,898	9/30/2025
2025 Q2	8/14/2025	11,217	0.0%	229,672	6/30/2025
2025 Q1	5/19/2025	9,109	0.0%	178,755	3/31/2025
2024 Q4	2/14/2025	7,234	0.0%	160,251	12/31/2024
2024 Q3	11/14/2024	4,971	0.0%	133,977	9/30/2024
2024 Q2	8/14/2024	4,660	0.0%	152,402	6/30/2024
2024 Q1	5/15/2024	2,301	0.0%	79,097	3/31/2024
2023 Q4	2/14/2024	2,180	0.0%	79,097	12/31/2023
2023 Q3	11/13/2023	1,697	0.0%	75,726	9/30/2023
2023 Q2	8/11/2023	3,560	0.0%	73,490	6/30/2023
2023 Q1	5/15/2023	3,560	0.0%	73,490	3/31/2023
2022 Q4	2/14/2023	2,591	0.0%	67,869	12/31/2022
2022 Q3	11/14/2022	13,151	0.0%	261,969	9/30/2022
2022 Q2	8/12/2022	11,067	0.0%	276,255	6/30/2022
2022 Q1	5/16/2022	17,431	0.0%	467,206	3/31/2022
2021 Q4	2/14/2022	19,127	0.0%	480,214	12/31/2021
2021 Q3	11/15/2021	17,761	0.0%	477,310	9/30/2021
2021 Q2	8/16/2021	19,461	0.0%	460,400	6/30/2021
2021 Q1	5/14/2021	14,972	0.0%	316,202	3/31/2021
2020 Q4	3/1/2021	27,106	0.0%	444,142	12/31/2020
2020 Q3	11/13/2020	19,983	0.0%	427,440	9/30/2020
2020 Q2	8/14/2020	24,953	0.0%	491,782	6/30/2020
2020 Q1	5/15/2020	16,420	0.0%	368,086	3/31/2020
2019 Q4	2/14/2020	19,145	0.0%	398,606	12/31/2019